PharmaCyte Biotech, Inc.
SEC insider (Form 3/4/5 filer). CIK 0001157075. 10% Owner at FEMASYS INC (FEMY) and 1 other issuer. 2 reported Form 4/5 transactions since Sep 2024; latest on Nov 14, 2025. Located in LAS VEGAS, NV.
Companies PharmaCyte Biotech, Inc. has filed insider reports for
- FEMASYS INC (FEMY): 10% Owner
- Q/C TECHNOLOGIES, INC. (QCLS): 10% Owner
PharmaCyte Biotech, Inc.
CIK: 0001157075
Transaction Breakdown
Open Market Buys (P)2 (100.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
